Asb Consultores, LLC Vertex Pharmaceuticals Inc Transaction History

Asb Consultores, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$421.16 - $509.5 $13,477 - $16,304	32 Added 5.56%	608 $270,000
Q1 2025 May 13, 2025	SELL	$402.49 - $513.76 $70,033 - $89,394	-174 Reduced 23.2%	576 $279,000
Q4 2024 Apr 23, 2025	SELL	$396.64 - $516.74 $80,517 - $104,898	-203 Reduced 21.3%	750 $302,000
Q3 2024 Oct 30, 2024	BUY	$460.0 - $505.78 $74,980 - $82,442	163 Added 20.63%	953 $443,000
Q2 2024 Aug 12, 2024	SELL	$392.81 - $485.53 $183,835 - $227,228	-468 Reduced 37.2%	790 $370,000

Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $512,874 - $561,168	1,258 New	1,258 $525,000

1,787

231M

1.83M

1.21M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Asb Consultores, LLC, based on Form 13F filings with the SEC.

Stay updated on Asb Consultores, LLC with notifications on news.